Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(9%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
7
64%
Ph early_phase_1
1
9%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(7)
Other(3)

Detailed Status

Completed7
unknown3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (12.5%)
N/A7 (87.5%)

Trials by Status

active_not_recruiting19%
unknown327%
completed764%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11